Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.46 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13772975 | 0.89 | SMN1; SMN2 (0.48) | ALDH1A1RAB9ASMN1; SMN2HSD17B10CYP2C19 | |
| SCHEMBL13772976 | 0.86 | TBXAS1 (0.52) | ALDH1A1RAB9ASMN1; SMN2HDAC6MAPT | |
| SCHEMBL11466037 | 0.85 | ALDH1A1 (0.47) | ALDH1A1RAB9ASMN1; SMN2KDM4ECYP2C19 | |
| SCHEMBL867896 | 0.80 | ALDH1A1 (0.53) | ALDH1A1RAB9ASMN1; SMN2KDM4ECYP2C19 | |
| SCHEMBL19051530 | 0.80 | LMNA (0.54) | ALDH1A1RAB9ASMN1; SMN2KDM4EHDAC6 | |
| SCHEMBL4600718 | 0.78 | CYP4F2 (0.50) | ALDH1A1SMN1; SMN2KDM4EHSD17B10GAA | |
| SCHEMBL18979709 | 0.77 | KEAP1 (0.41) | ALDH1A1KDM4EKEAP1HSD17B10ALOX15 | |
| SCHEMBL28630338 | 0.76 | ALDH1A1 (0.52) | ALDH1A1RAB9ASMN1; SMN2KDM4ECYP2C19 | |
| SCHEMBL9645804 | 0.75 | ALDH1A1 (0.51) | ALDH1A1KDM4EKEAP1HSD17B10ALOX15 | |
| SCHEMBL4450606 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119040440-A | Extended microscopic method suitable for protein and nucleic acid super-resolution co-imaging and application thereof | 上海交通大学 | 2024-11-29 | — | — | CN | disclosed |
| EP-3700911-B1 | NOVEL MACROCYCLIC DERIVATIVES, PROCESS FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | SERVIER LAB (FR) | 2023-09-06 | — | — | EP | disclosed |
| EP-3700911-A1 | NOVEL MACROCYCLIC DERIVATIVES, PROCESS FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | Les Laboratoires Servier SAS (FR) | 2020-09-02 | — | — | EP | disclosed |
| US-9981018-B2 | Compositions and methods for modulating toll-like receptor 2 activation | THE CLEVELAND CLINIC FOUNDATION (US) | 2018-05-29 | — | — | US | disclosed |
| US-7560257-B2 | Diagnostic methods for age related macular degeneration | THE CLEVELAND CLINIC FOUNDATION (US) | 2009-07-14 | — | — | US | disclosed |
| US-20080160505-A1 | DIAGNOSTIC METHODS FOR AGE RELATED MACULAR DEGENERATION | THE CLEVELAND CLINIC FOUNDATION | 2008-07-03 | — | — | US | disclosed |
| US-7341839-B2 | Diagnostic methods for age related macular degeneration | THE CLEVELAND CLINIC FOUNDATION (US) | 2008-03-11 | — | — | US | disclosed |
| US-20070072241-A1 | diagnosing age-related macular degeneration comprising determining the level of anti-2-( omega -carboxyethyl) pyrrole (CEP) antibodies in a bodily fluid obtained from the test subject | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-03-29 | — | — | US | disclosed |
| US-7172874-B2 | Diagnostic methods for age related macular degeneration | THE CLEVELAND CLINIC FOUNDATION (US) | 2007-02-06 | — | — | US | disclosed |
| EP-0800390-B1 | CYCLOPROPYLPYRROLOINDOLE-OLIGOPEPTIDE ANTICANCER AGENTS | UNIV ALBERTA (CA) | 2002-12-04 | — | — | EP | disclosed |
| EP-0800390-A4 | CYCLOPROPYLPYRROLOINDOLE-OLIGOPEPTIDE ANTICANCER AGENTS | SYNPHAR LAB INC (CA) | 1999-01-20 | — | — | EP | disclosed |
| EP-0800390-A1 | CYCLOPROPYLPYRROLOINDOLE-OLIGOPEPTIDE ANTICANCER AGENTS | SYNPHAR LABORATORIES INC. (CA) | 1997-10-15 | — | — | EP | disclosed |
| WO-1996023497-A1 | CYCLOPROPYLPYRROLOINDOLE-OLIGOPEPTIDE ANTICANCER AGENTS | SYNPHAR LABORATORIES, INC. (CA) | 1996-08-08 | — | — | WO | disclosed |
| US-5502068-A | ABILITY TO ALKYLATE DNA SEQUENCES | SYNPHAR LABORATORIES, INC. (CA) | 1996-03-26 | — | — | US | disclosed |